Protokinetix Inc (PKTX)
ProtoKinetix, Incorporated is a research and development-stage biotechnology company listed on OTC Markets under the common stock symbol PKTX. The company focuses on medical and scientific research involving anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). According to the company description, these compounds are associated with commercial applications in targeted healthcare solutions and in areas such as ophthalmology, dermatology, transplants, and biomanufacturing. ProtoKinetix was originally incorporated in 1999 and adopted its current name in July 2003. It is based in Dalton, Ohio.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-PKTX
|
$0.00030
|
-97.3% Downside
|
Expensive
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 13, 2026
|
0.3x
|
82.326 K
|
81.208 K
|
0.0%
|
81.1%
|
-32,083.8
|
34.4%
|
